These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 32347995)
1. High glucose level as a modifier factor in CMT1A patients. Secchin JB; Leal RCC; Lourenço CM; Marques VD; Nogueira PTL; Santos ACJ; Tomaselli PJ; Marques W J Peripher Nerv Syst; 2020 Jun; 25(2):132-137. PubMed ID: 32347995 [TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus exacerbates motor and sensory impairment in CMT1A. Sheth S; Francies K; Siskind CE; Feely SM; Lewis RA; Shy ME J Peripher Nerv Syst; 2008 Dec; 13(4):299-304. PubMed ID: 19192070 [TBL] [Abstract][Full Text] [Related]
3. Coexistence of Charcot Marie Tooth disease type 1A and diabetes in Taiwan: A clinicopathological study. Chao HC; Chou CT; Lee YC; Lin KP J Neurol Sci; 2015 Nov; 358(1-2):213-20. PubMed ID: 26349404 [TBL] [Abstract][Full Text] [Related]
5. Influence of comorbidities on the phenotype of patients affected by Charcot-Marie-Tooth neuropathy type 1A. Ursino G; Alberti MA; Grandis M; Reni L; Pareyson D; Bellone E; Gemelli C; Sabatelli M; Pisciotta C; Luigetti M; Santoro L; Massollo L; Schenone A Neuromuscul Disord; 2013 Nov; 23(11):902-6. PubMed ID: 23891256 [TBL] [Abstract][Full Text] [Related]
6. Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot-Marie-Tooth disease type 1A. Bjelica B; Peric S; Bozovic I; Jankovic M; Brankovic M; Palibrk A; Rakocevic Stojanovic V Acta Neurol Belg; 2021 Dec; 121(6):1481-1486. PubMed ID: 32335868 [TBL] [Abstract][Full Text] [Related]
7. Afferent control of walking: are there distinct deficits associated to loss of fibres of different diameter? Nardone A; Corna S; Turcato AM; Schieppati M Clin Neurophysiol; 2014 Feb; 125(2):327-35. PubMed ID: 23948160 [TBL] [Abstract][Full Text] [Related]
8. Motor performance deterioration accelerates after 50 years of age in Charcot-Marie-Tooth type 1A patients. Tozza S; Bruzzese D; Pisciotta C; Iodice R; Esposito M; Dubbioso R; Ruggiero L; Topa A; Spina E; Santoro L; Manganelli F Eur J Neurol; 2018 Feb; 25(2):301-306. PubMed ID: 29053907 [TBL] [Abstract][Full Text] [Related]
9. Nerve conduction velocity in CMT1A: what else can we tell? Manganelli F; Pisciotta C; Reilly MM; Tozza S; Schenone A; Fabrizi GM; Cavallaro T; Vita G; Padua L; Gemignani F; Laurà M; Hughes RA; Solari A; Pareyson D; Santoro L; Eur J Neurol; 2016 Oct; 23(10):1566-71. PubMed ID: 27412484 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiological characterization of Charcot-Marie-Tooth disease type 1A in Taiwan. Huang LW; Lin KP; Chang MH; Liao YC; Liao KK; Soong BW; Lee YC J Chin Med Assoc; 2012 May; 75(5):197-202. PubMed ID: 22632984 [TBL] [Abstract][Full Text] [Related]
12. Charcot-Marie-Tooth disease and related inherited neuropathies. Murakami T; Garcia CA; Reiter LT; Lupski JR Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346 [TBL] [Abstract][Full Text] [Related]
13. Autonomic Neuropathy and Endothelial Dysfunction in Patients With Impaired Glucose Tolerance or Type 2 Diabetes Mellitus. Tiftikcioglu BI; Bilgin S; Duksal T; Kose S; Zorlu Y Medicine (Baltimore); 2016 Apr; 95(14):e3340. PubMed ID: 27057914 [TBL] [Abstract][Full Text] [Related]
14. Charcot-Marie-Tooth Disease Type 1A: Influence of Body Mass Index on Nerve Conduction Studies and on the Charcot-Marie-Tooth Examination Score. Jerath NU; Shy ME J Clin Neurophysiol; 2017 Nov; 34(6):508-511. PubMed ID: 28914656 [TBL] [Abstract][Full Text] [Related]
15. Coexistence of two chronic neuropathies in a young child: Charcot-Marie-Tooth disease type 1A and chronic inflammatory demyelinating polyneuropathy. Marques W; Funayama CA; Secchin JB; Lourenço CM; Gouvêa SP; Marques VD; Bastos PG; Barreira AA Muscle Nerve; 2010 Oct; 42(4):598-600. PubMed ID: 20878740 [TBL] [Abstract][Full Text] [Related]
16. The impact of symptoms on daily life as perceived by patients with Charcot-Marie-Tooth type 1A disease. Tozza S; Bruzzese D; Severi D; Spina E; Iodice R; Ruggiero L; Dubbioso R; Iovino A; Aruta F; Nolano M; Santoro L; Manganelli F Neurol Sci; 2022 Jan; 43(1):559-563. PubMed ID: 33899151 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic spectrum of Charcot-Marie-Tooth disease due to LITAF/SIMPLE mutations: a study of 18 patients. Guimarães-Costa R; Iancu Ferfoglia R; Leonard-Louis S; Ziegler F; Magy L; Fournier E; Dubourg O; Bouche P; Maisonobe T; Lacour A; Moerman A; Latour P; Stojkovic T Eur J Neurol; 2017 Mar; 24(3):530-538. PubMed ID: 28211240 [TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Singleton JR; Smith AG; Bromberg MB Diabetes Care; 2001 Aug; 24(8):1448-53. PubMed ID: 11473085 [TBL] [Abstract][Full Text] [Related]
19. Upper and lower limb tremor in Charcot-Marie-Tooth neuropathy type 1A and the implications for standing balance. Silsby M; Yiannikas C; Fois AF; Kennerson ML; Kiernan MC; Fung VSC; Vucic S J Neurol; 2024 Apr; 271(4):1776-1786. PubMed ID: 38051345 [TBL] [Abstract][Full Text] [Related]
20. Paternal gender specificity and mild phenotypes in Charcot-Marie-Tooth type 1A patients with de novo 17p12 rearrangements. Lee AJ; Nam DE; Choi YJ; Noh SW; Nam SH; Lee HJ; Kim SJ; Song GJ; Choi BO; Chung KW Mol Genet Genomic Med; 2020 Sep; 8(9):e1380. PubMed ID: 32648354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]